ALNYLAM PHARMACEUTICALS INC COM USD0.01ALNYLAM PHARMACEUTICALS INC COM USD0.01ALNYLAM PHARMACEUTICALS INC COM USD0.01

ALNYLAM PHARMACEUTICALS INC COM USD0.01

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−1.14USD
Revenue estimate
‪428.05 M‬USD
Market capitalization
‪18.18 B‬USD
−3.55USD
‪−440.24 M‬USD
‪1.83 B‬USD
‪125.76 M‬
Beta (1Y)
1.30

About ALNYLAM PHARMACEUTICALS INC COM USD0.01

CEO
Yvonne L. Greenstreet
Headquarters
Cambridge
Employees (FY)
‪2.1 K‬
Founded
2002
FIGI
BBG00JVRN4W5
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where 0HD2 is featured.

Frequently Asked Questions

The current price of 0HD2 is 142.30 USD — it has decreased by 1.34% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ALNYLAM PHARMACEUTICALS INC COM USD0.01 stocks are traded under the ticker 0HD2.
ALNYLAM PHARMACEUTICALS INC COM USD0.01 is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
0HD2 stock is 1.56% volatile and has beta coefficient of 1.30. Check out the list of the most volatile stocks — is ALNYLAM PHARMACEUTICALS INC COM USD0.01 there?
0HD2 earnings for the last quarter are 1.15 USD per share, whereas the estimation was −1.45 USD resulting in a 179.55% surprise. The estimated earnings for the next quarter are −1.19 USD per share. See more details about ALNYLAM PHARMACEUTICALS INC COM USD0.01 earnings.
ALNYLAM PHARMACEUTICALS INC COM USD0.01 revenue for the last quarter amounts to ‪750.53 M‬ USD despite the estimated figure of ‪396.76 M‬ USD. In the next quarter revenue is expected to reach ‪436.92 M‬ USD.
Yes, you can track ALNYLAM PHARMACEUTICALS INC COM USD0.01 financials in yearly and quarterly reports right on TradingView.
0HD2 stock has fallen by 1.85% compared to the previous week, the month change is a 6.68% fall, over the last year ALNYLAM PHARMACEUTICALS INC COM USD0.01 has showed a 29.27% decrease.
0HD2 net income for the last quarter is ‪−137.87 M‬ USD, while the quarter before that showed ‪147.75 M‬ USD of net income which accounts for −193.31% change. Track more ALNYLAM PHARMACEUTICALS INC COM USD0.01 financial stats to get the full picture.
Today ALNYLAM PHARMACEUTICALS INC COM USD0.01 has the market capitalization of ‪18.18 B‬, it has decreased by 0.63% over the last week.
No, 0HD2 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0HD2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALNYLAM PHARMACEUTICALS INC COM USD0.01 stock right from TradingView charts — choose your broker and connect to your account.
0HD2 reached its all-time high on Jan 17, 2023 with the price of 241.05 USD, and its all-time low was 65.00 USD and was reached on Nov 15, 2018.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has ‪2.10 K‬ employees. See our rating of the largest employees — is ALNYLAM PHARMACEUTICALS INC COM USD0.01 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALNYLAM PHARMACEUTICALS INC COM USD0.01 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALNYLAM PHARMACEUTICALS INC COM USD0.01 stock shows the sell signal. See more of ALNYLAM PHARMACEUTICALS INC COM USD0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ALNYLAM PHARMACEUTICALS INC COM USD0.01 future price: according to them, 0HD2 price has a max estimate of 395.00 USD and a min estimate of 136.00 USD. Read a more detailed ALNYLAM PHARMACEUTICALS INC COM USD0.01 forecast: see what analysts think of ALNYLAM PHARMACEUTICALS INC COM USD0.01 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALNYLAM PHARMACEUTICALS INC COM USD0.01 EBITDA is ‪−228.12 M‬ USD, and current EBITDA margin is −12.48%. See more stats in ALNYLAM PHARMACEUTICALS INC COM USD0.01 financial statements.